期刊文献+

基质金属蛋白酶抑制物-2基因转移对家兔动脉粥样硬化斑块的影响 被引量:1

Effects of TIMP-2 gene transfer on atherosclerotic plaque in rabbits
原文传递
导出
摘要 目的探讨局部转染金属蛋白酶抑制物(pcDNA3TIMP2)基因对动脉粥样硬化斑块的影响。方法内皮剥脱加高脂饮食建立兔动脉粥样硬化动物模型,基因球囊局部转染pcDNA3TIMP2,RT PCR和Westernblot分别检测动脉粥样硬化斑块局部外源基因转移效果,Zymography检测动脉粥样硬化斑块局部基质金属蛋白酶(MMPs)活性,病变股动脉组织行HE和苦味酸酸性品红染色,全自动图像分析仪行图像处理,测量血管腔面积、胶原成分含量。结果基因转染组术后2周动脉粥样硬化局部TIMP2基因表达即明显高于空白载体对照组(P<0.01),术后4周达高峰;术后2、4、8周TIMP2蛋白表达也明显高于空白载体对照组(P<0.01),MMP2和MMP9活性低于对照组。局部转染TIMP2基因组动物,动脉粥样硬化斑块纤维帽厚度和病变局部胶原含量均明显高于对照组,但病变血管腔面积与对照组差异则无统计学意义。结论动脉粥样硬化局部转移TIMP2基因可明显抑制病变局部MMP2和MMP9活性,增加动脉粥样硬化斑块纤维帽厚度和病变局部胶原含量,但对动脉粥样硬化所致血管腔狭窄程度无明显影响。 ObjectiveTo evaluate the effects of TIMP-2 local gene transfer on atherosclerotic plaque. MethodsAtherosclerosis models were induced by denuding femoral artery endothelium plus high lipid diet in rabbits. TIMP-2 gene was transferred locally by balloons eluted with pcDNA3-TIMP-2. RT-PCR and Western blot were performed to verify exogenous genes transfer. MMPs activity in atherosclerotic plaque was evaluated by zymography. HE and VG staining and automatic image analysis system were used for pathological analysis of atherosclerotic femoral arteries. The lumen area of the vessel and the collagen contents in the atherosclerotic plaque were measured. ResultsThe expression of TIMP-2 gene in pcDNA3-TIMP-2 transferred group was significantly higher than control-vector transferred group at the end of week 2 after operation and reached the peak at the end of week 4. Comparing with the control group, the expression of TIMP-2 protein in treated group was also higher at the end of week 2, 4, and 8 after operation. Correspondingly, the MMP-2 and MMP-9 activities were lower in treated group. The thickness of fibrous cap of atherosclerotic plaque and the amount of collagen of the lesion were increased significantly in treated group compared with the control group, but there were no significant differences in vessel lumen area. Conclusion TIMP-2 gene transfer locally in atherosclerotic plaque could inhibit the activities of MMP-2 and MMP-9 in the lesion, increase the thickness of fibrous cap and the amount of collagen of the lesion, but may have no effect on the degree of the stenosis.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2005年第5期405-410,共6页 Chinese Journal of Cardiology
基金 上海市青年科技启明星计划(98QB14014)
  • 相关文献

参考文献1

二级参考文献13

  • 1[1]Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling[J]. FASB J, 1991, 5: 2145-2154.
  • 2[2]Stetler Stevenson WG, Liotta LA, Kleiner DE, et al. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis[J]. FASEB J,1993, 7: 1 434-1 441.
  • 3[3]Dolley C, McEwan J, Henney A. Matrix metalloproteinases and cardiovascular disease[J]. Circ Res,1995,77: 863-868.
  • 4[4]Ye S, Watts GF, Mandalia S, et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atheroscierosis[J]. Br Heart J,1995, 73: 209-215.
  • 5[5]Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaque[J]. J Clin Invest, 1994, 94: 2493-2503.
  • 6[6]Brown DL, Hibbs MS, Keamey M, et al. Identification of 92 kDa gelatinase in human coronary athrosclerotic lesions: association of active enzyme synthesis with unstable angina[J]. Circulation, 1995,91: 2125-2131.
  • 7[7]Li Z, Li L, Zielke HR, et al. Increased expression of 72 kDa type Ⅳ collagenase (MMP 2) in human aortic atherosclerotic lesions[J]. Am J Pathol, 1996, 148: 121-128.
  • 8[8]Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity[J]. Ann N Y Acad Sci, 1994, 732: 31-41.
  • 9[9]Overall CM, Wrana TL, Sodek J, et al. Tanscriptional and post transcriptional regulation of 72 kd gelatinase/type Ⅳ collagenase by transforming grouth factor beta in human fibroblasts comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression[J]. J Biol Chem, 1991, 266: 14064-14071.
  • 10[10]Yoshiji H, Buck TB, Harris SR, et al. Stimulatory effect of endogenous tissue inhibitor of metalloproteinases 1 (TIMP 1) overexpression on type Ⅳ collegen and laminin gene expression in rat mammary carcinoma cells[J]. Biochem Biophy Res Comm, 1998, 247(3): 605-609.

同被引文献14

  • 1Ridker PM,Rifai N,Stampfer MJ,et al.Plasma concentration of interleukin and the risk of future myocardial infraction among apparently healthy men[J].Circulation,2000; 101:1767-72.
  • 2Luan ZX,Chase A J,Newby AC.Statins inhibit secretion of metalloproteinase-1 、-2、-3 and -9 from vascular smooth muscles cells and macrophages[J].Atheroscler Thromb Vase Biol,2003 ;23 (5):769-75.
  • 3Davies MJ,Pathophysiology of acute coronary syndromes[J].Heart,2000 ;83:361-6.
  • 4Knapp AC,Huang J,Starling G,et al.Inhibitors of HMG-COA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death[J].Atherosclerosis,2000; 152:217-27.
  • 5Li JJ.Silent myocardial ischemia may be related to inflammatory response[J].Med Hypootheses,2004 ;62:252-6.
  • 6Mack WJ,LaBree L,Liu C,et al.Correlation between measures of atherosclerosis change using carotid ultrasongpgraphy and coronary angiography[J].Atherosclerosis,2000; 150:371-9.
  • 7Gotto FM.Lipid-lowering therapy for the primary prevention of coronary heart disease[J].J Am Coll Cardiol,1999 ;33:2078-82.
  • 8Davies MJ.Apoptosis in cardiovascular disease[J].Heart,1997 ;77:498-501.
  • 9Kockx MM,Muhring J,Bortier H,et al.Biotin or digoxigenin conjugated Nucleotides bind to matrix vesicles in atherosclerotic plaques[J].Am J Pathol,1996; 148:1771-7.
  • 10Flynn PD,Byrne CD,Baglin TP,et al.Thrombin generation by apoptotic vascular smooth muscle cells[J].Blood,1997 ;89:4378-84.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部